期刊文献+

子痫前期的高危预警因素及筛查管控 被引量:3

High-risk warning factors and screening control for preeclampsia
暂未订购
导出
摘要 子痫前期作为妊娠期特有的疾病之一,以高血压为典型临床表现,伴或不伴蛋白尿、水肿,可有抽搐、昏迷、视物模糊等症状,病情严重者可发展为子痫。子痫前期若不能及时有效干预,可突发紧急状况,危及孕产妇及围生儿的生命。该疾病的临床表现较为复杂,常合并多器官功能损害,不利于临床医生及时诊治,因此若能全面监测子痫前期的预警信息,尽早选择合适的筛查方式及预防措施,将关口前移,不仅为母婴安全提供保障,而且为产科临床实践提供理论依据。 Preeclampsia,as one of the diseases peculiar to pregnancy,is characterized by hypertension,with or without proteinuria and edema,and may have convulsions,coma,blurred vision and other symptoms.In severe cases,it may develop into eclampsia.Without timely and effective intervention,preeclampsia can be an emergency that endangers the lives of pregnant women and their perinatal children.The clinical manifestations of the disease is relatively complex,often combined with multiple organ dysfunction,is not conducive to clinical doctor make a diagnosis and give treatment in time.Therefore,if the warning information of preeclampsia can be comprehensively monitored,the right means of screening and prevention measures can be taken as soon as possible,and the key window can be move forward,it will not only ensure the security of maternal and infant,but also provide theory basis for obstetric clinical practice.
作者 胡翠芳 黄畅晓 李力 HU Cuifang;HUANG Changxiao;LI Li(Department of Obstetrics and Gynecology Center,Daping Hospital,Army Medical University,Chongqing 400042,China)
出处 《中国妇幼健康研究》 2022年第10期123-126,共4页 Chinese Journal of Woman and Child Health Research
基金 国家自然科学基金(31470886) 重庆市自然科学基金(cstc2019jcyj-msxm0680)。
关键词 子痫前期 关口前移 筛查 管控措施 preeclampsia move forward key window screening management measures
  • 相关文献

参考文献2

二级参考文献24

  • 1谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 2Steegers E A, von-Dadelszen P, Duvekot J J, et al. Pre-eclampsia [J]. Lancet, 2010, 376(9741) 631 -644.
  • 3Dusse, L M, Carvalho M G, Cooper A J, et al. Plasma factor VII: a potential marker of pre-eclampsia[ J]. Thromb Res, 2011, 127 ( 1 ) : el5 -el9.
  • 4Gardiner C, Tannetta D S, Simms C A, et al. Syncytiotrophoblast mi- erovesicles released from pre-eclampsia placentae exhibit increased tis- sue factor activity [ J ]. PLoS One, 2011, 6 ( 10 ) : e26313.
  • 5Xiong Y, Zhou S F, Zhou R, et al. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery [ J ]. Hy- pertens Pregnancy, 2011, 30 (3) : 347 - 358.
  • 6Lwaleed B A, Dusse L, Cooper A J. Tissue factor dependent pathway and the diagnosis of pre-eclampsia [ J ]. Semin Thromb Hemost, 2011, 37(2) : 125 -130.
  • 7Dusse L M, Rios D R, Pinheiro M B, et al. Pre-eelampsia: relation- ship between coagulation, fibrinolysis and inflammation [ J ]. Clin Chim Acta, 2011,412(1/2) : 17 -21.
  • 8Ismail S K, Higgins J R. Hemostasis in pre-eelampsia [ J ]. Semin Thromb Hemost, 2011, 37 (2) : 111 - 117.
  • 9van-der-Post J A, Lok C A, Boer K, et al. The functions of micropar- ticles in pre-eclampsia [ J ]. Semin Thromb Hemost, 2011, 37 (2) : 146 - 152.
  • 10Kleinrouweler C E, Wiegerinek M M, Ris-Stalpers C, et al. Accura- cy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis [J]. BJOG, 2012, 119(7) : 778 -787.

共引文献196

同被引文献49

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部